Dian Diagnostics Group Co Ltd
SZSE:300244
Relative Value
The Relative Value of one Dian Diagnostics Group Co Ltd stock under the Base Case scenario is 46.64 CNY. Compared to the current market price of 14.1 CNY, Dian Diagnostics Group Co Ltd is Undervalued by 70%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Dian Diagnostics Group Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Dian Diagnostics Group Co Ltd
SZSE:300244
|
8.8B CNY | 0.6 | -19 | 14.5 | 14.5 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
98.9B EUR | 0.5 | 20.5 | 10.5 | 14 | |
US |
Cigna Corp
NYSE:CI
|
100.8B USD | 0.5 | 19.5 | 10.1 | 13.4 | ||
US |
CVS Health Corp
NYSE:CVS
|
71B USD | 0.2 | 8.5 | 7.8 | 7.8 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.9B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 39 | 11.9 | 17.9 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 1.6 | 18 | 10.8 | 14.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 23.6 | 7 | 16.5 | |
US |
DaVita Inc
NYSE:DVA
|
12.6B USD | 1 | 18.3 | 8.7 | 12.8 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.1 | 6.9 | 16.3 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |